Clinical guidelines «Obesity in children»
https://doi.org/10.14341/omet13194
Abstract
Childhood obesity is an urgent problem of pediatric endocrinology due to the widespread occurrence, the development of metabolic complications and their steady tracking into adulthood. The developed clinical guidelines are the main working tool of the practitioner. They briefly and structurally present the main information about the epidemiology and modern classification of obesity, methods of its diagnosis and treatment based on the principles of evidence-based medicine.
About the Authors
O. V. VasyukovaRussian Federation
Olga V. Vasyukova, MD
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
P. L. Okorokov
Russian Federation
Pavel L. Okorokov, MD
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
O. A. Malievskiy
Russian Federation
Oleg A. Malievskiy, MD
Competing Interests:
None
A. E. Neimark
Russian Federation
Aleksandr E. Neimark, MD, PhD
Competing Interests:
None
E. A. Zorin
Russian Federation
Evgeny A. Zorin, MD, PhD
Competing Interests:
None
Y. I. Yashkov
Russian Federation
Yury I. Yashkov, MD, PhD
Competing Interests:
None
Yu. V. Burmitskaya
Russian Federation
Yulia V. Burmitskaya, MD
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
D. A. Kopytina
Russian Federation
Daria A. Kopytina, MD
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
O. B. Bezlepkina
Russian Federation
Olga B. Bezlepkina, PhD, Professor
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
V. A. Peterkova
Russian Federation
Valentina A. Peterkova, PhD, professor, academician of Russian Academy of Medical Sciences
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
None
References
1. Peterkova VA, Bezlepkina OB, Bolotova NV, et al. Clinical guidelines «Obesity in children». Problems of Endocrinology. 2021;67(5):67-83. (In Russ.) doi: https://doi.org/10.14341/probl12802
2. Peterkova VA, Vasyukova OV. About the new classification of obesity in the children and adolescents. Problems of Endocrinology. 2015;61(2):39-44. (In Russ.). doi: https://doi.org/10.14341/probl201561239-44
3. Peterkova VA, Vasyukova OV. Redkie formy ozhireniya u detej. Lechashchij vrach. 2008;3:29-33 (In Russ.).
4. González-álvarez MA, Lázaro-Alquézar A, Simón-Fernández MB. Global trends in child obesity: Are figures converging? Int J Environ Res Public Health. 2020. doi: https://doi.org/10.3390/ijerph17249252
5. Tutelyan VA, Baturin AK, Kon IYa. Prevalence of overweight and obesity in child population of Russia: multicenter study. Pediatria n.a. G.N. Speransky. 2014; 93 (5):28-31. (In Russ.)
6. Gritsinskaya VL, Novikova VP, Khavkin AI. Epidemiology of obesity in children and adolescents (systematic review and metaanalysis of publications over a 15-year period). Vopr. prakt. pediatr. (Clinical Practice in Pediatrics). 2022;17(2):126–135. (In Russian). doi: https://doi.org/10.20953/1817-7646-2022-2-126-135
7. Styne DM, Arslanian SA, Connor EL, et al. Pediatric obesityassessment, treatment, and prevention: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017. doi: https://doi.org/10.1210/jc.2016-2573
8. Vasyukova OV. Obesity in children and adolescents: diagnosis criteria. Obesity and metabolism. 2019;16(1):70-73. (In Russ.) doi: https://doi.org/10.14341/omet10170
9. Peterkova VA, Nagaeva EV, Shiryaeva TYu. Metodicheskie rekomendatsii: Otsenka fizicheskogo razvitiya detei i podrostkov. Moscow; 2017. 98 c. (In Russ.)
10. Rekomendatsii po diagnostike, lecheniyu i profilaktike ozhireniya u detei i podrostkov. Moscow: Praktika; 2015. 136 p. (In Russ.)
11. Ibáñez L, Oberfield SE, Witchel S, et al. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm Res Paediatr. 2017;88(6):371-395. doi: https://doi.org/10.1159/000479371
12. Peterkova VA, Remizov OV. Ozhirenie v detskom vozraste. Obesity and metabolism. 2004;1(1):17-23. (In Russ.). doi: https://doi.org/10.14341/2071-8713-5174
13. Marcus CL, Brooks LJ, Draper KA, et al: American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130(3):e714-55. doi: https://doi.org/10.1542/peds.2012-1672
14. Aleksandrov AA, Kisliak OA, Leontyeva IV. Clinical guidelines on arterial hypertension diagnosis, treatment and prevention in children and adolescents. Systemic Hypertension. 2020;17(2):7-35. (In Russ.) doi: https://doi.org/10.26442/2075082X.2020.2.200126
15. Agapitov LI, Aleksandrov AA, Baranov AA, et al. Arterial’naya gipertenziya u detei. Klinicheskie rekomendatsii MZ RF. 2016. (In Russ.)
16. Molleston JP, Schwimmer JB, Yates KP, et al. Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels. J Pediatr. 2014;164(4):707-713. doi: https://doi.org/10.1016/j.jpeds.2013.10.071
17. Ivashkin VT, Mayevskaya MV, Pavlov ChS, et al. Diagnostics and treatment of non-alcoholic fatty liver disease: clinical guidelines of the Russian Scientific Liver Society and the Russian gastroenterological association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(2):24-42. (In Russ.). doi: https://doi.org/10.22416/1382-4376-2016-26-2-24-42
18. Mayer-Davis EJ, Kahkoska AR, Jefferies C, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018;19:7-19. doi: https://doi.org/10.1111/pedi.12773
19. Mayer-Davis EJ, Kahkoska AR, Jefferies C, et al. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes — 2020. Diabetes Care. 2020;43(S1):S14-S31. doi: https://doi.org/10.2337/dc20-S002
20. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. WHO; IDF: 2006
21. Giorgio V., Graziano F., Nobili V. Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr. 2013;13:40
22. Ivashkin VT, Maev IV, Baranskaya EK, et al. Rekomendatsii Rossiiskoi gastroenterologicheskoi assotsiatsii po diagnostike i lecheniyu zhelchnokamennoi bolezni. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(3):64-80. (In Russ.). doi: https:// doi.org/10.22416/1382-4376-2016-26-3-64-80
23. Comnologiya i meditsina sna. Natsional’noe rukovodstvo pamyati AM Veina i YaI Levina. Ed. by Poluektov MG. Moscow: Medforum; 2016. (In Russ.)
24. Kaditis AG, Alonso Alvarez ML, et al. Obstructive sleep disordered breathing in 2- to 18-year-old children: diagnosis and management. Eur Respir J. 2016;47(1):69-94. doi: https://doi.org/10.1183/13993003.00385-2015
25. Solano-Pérez E, Coso C, Castillo-García M, et al. Diagnosis and Treatment of Sleep Apnea in Children: A Future Perspective Is Needed. Biomedicines. 2023;11:1708. doi: https://doi.org/10.3390/biomedicines11061708
26. Arslanian SA. Clamp Techniques in Paediatrics: What Have We Learned? Horm Res Paediatr. 2005;64(3):16-24. doi: https://doi.org/10.1159/000089313
27. Levy-Marchal C, Arslanian S, Cutfield W, et al. Insulin Resistance in Children: Consensus, Perspective, and Future Directions. J Clin Endocrinol Metab. 2010;95(12):5189-5198. doi: https://doi.org/10.1210/jc.2010-1047
28. Yeckel CW, Weiss R, Dziura J, et al. Validation of Insulin Sensitivity Indices from Oral Glucose Tolerance Test Parameters in Obese Children and Adolescents. J Clin Endocrinol Metab. 2004;89(3):1096-1101. doi: https://doi.org/10.1210/jc.2003-031503
29. Vasyukova OV. Insulin, leptin, lipidy i perifericheskie rostovye faktory pri ozhirenii u detei. dissertation Moscow: 2006. 24 p. (In Russ.)
30. Takahara M, Katakami N, Kaneto H, Noguchi M, Shimomura I. Distribution of the Matsuda Index in Japanese healthy subjects. J Diabetes Investig. 2013;4(4):369-371. doi: https://doi.org/10.1111/jdi.12056
31. Kai-Yu Xiong, Hui He, Yi-Ming Zhang, et al. Analyses of body composition charts among younger and older Chinese children and adolescents aged 5 to 18 years. BMC Public Health. 2012;12:835-844
32. McCarthy HD, Samani-Radia D, Jebb SA, et al. Skeletal muscle mass reference curves for children and adolescents. Pediatric Obesity. 2013. doi: https://doi.org/10.1111/j.2047-6310.2013.00168.x
33. Demura S, Sato S, Kitabayashi T. Percentage of Total Body Fat as Estimated by Three Automatic Bioelectrical Impedance Analyzers. J Physiol Anthropol Appl Human Sci. 2004;23(3):93-99. doi: https://doi.org/10.2114/jpa.23.93
34. Malavolti M, Mussi C, Poli M, et al. Cross-calibration of eight-polar bioelectrical impedance analysis versus dualenergy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years. Ann Hum Biol. 2003;30(4):380-391. doi: https://doi.org/10.1080/0301446031000095211
35. Kedrinskaya AG, Obraztsova GI, Leonova IA. Component composition of the body in children with excessive body mass and obesity. Russ Pediatr J. 2019;21(2):73-77. (In Russ.). doi: https://doi.org/10.18821/1560-9561-2018-21-2-73-77
36. The Academy of Nutrition and Dietetics. Evidence Analysis Library. Pediatric Weight Management Guidelines. 2015. Available from: http://www.adaevidencelibrary.com/topic.cfm?cat=2721
37. Barlow SE. Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report. Pediatrics. 2007;120(S4):S164-S192. doi: https://doi.org/10.1542/peds.2007-2329C
38. Mead E, Brown T, Rees K, et al. Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years. Cochrane Database Syst Rev. 2017;2017(6). doi: https://doi.org/10.1002/14651858.CD012651
39. Pavlovskaya EV, Surkov AG, Shilina NM, et al. Modern approaches to diet therapy for obesity in children. Vopr Det Dietol. 2016;14(1):41-46. (In Russ.). doi: https://doi.org/10.20953/1727-5784-2016-1-41-46
40. Holm J-C, Gamborg M, Bille DS, et al. Chronic care treatment of obese children and adolescents. Int J Pediatr Obes. 2011;6(3-4):188-196. doi: https://doi.org/10.3109/17477166.2011.575157
41. Aleksandrov AA, Bubnova MG, Kislyak OA, et al. Profilaktika serdechno-sosudistykh zabolevanii v detskom i podrostkovom vozraste. Rossiiskie rekomendatsii. Rossiiskii kardiologicheskii zhurnal. 2012;6(98S1):1-40. (In Russ.)
42. WHO. Global’nye rekomendatsii po fizicheskoi aktivnosti dlya zdorov’ya. Moscow: 2010. 60 p. (In Russ.)
43. WHO. WHO guidelines on physical activity, sedentary behavior and sleep for children under 5 years of age. 2019 ISBN 978-92-4-155053-6
44. Morrissey B, Taveras E, Allender S,et al.. Sleep and obesity among children: A systematic review of multiple sleep dimensions. Pediatr Obes. 2020 Apr;15(4):e12619. doi: 10.1111/ijpo.12619..
45. Kahle E, Zijpf W, Lamb D, et al. Association Between Mild, Routine Exercise and Improved Insulin Dynamics and Glucose Control in Obese Adolescents. Int J Sports Med. 1996;17(01):1-6. doi: https://doi.org/10.1055/s-2007-972799
46. McMurray RG, Bauman MJ, Harrell JS, et al. Effects of improvement in aerobic power on resting insulin and glucose concentrations in children. Eur J Appl Physiol Occup Physiol. 2000;81(1-2):132-139. doi: https://doi.org/10.1007/PL00013786
47. Ritenbaugh C, Teufel-Shone NI, Aickin MG, et al. A lifestyle intervention improves plasma insulin levels among Native American high school youth. Prev Med (Baltim). 2003;36(3):309-319. doi: https://doi.org/10.1016/S0091-7435(02)00015-4
48. Axon E, Atkinson G, Richter B, et al. Drug interventions for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev. 2016;11(11):CD012436. doi: https://doi.org/10.1002/14651858.CD012436
49. Kelly AS, Auerbach P, Barrientos-Perez M, et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. N Engl J Med. 2020;382(22):2117-2128. doi: https://doi.org/10.1056/NEJMoa1916038
50. Mastrandrea LD, Witten L, Carlsson Petri KC, et al. Liraglutide effects in a paediatric (7‐11 y) population with obesity: A randomized, double‐blind, placebo‐controlled, shortterm trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. Pediatr Obes. 2019;14(5):e12495. doi: https://doi.org/10.1111/ijpo.12495
51. Chanoine J-P, Hampl S, Jensen C, et al. Effect of Orlistat on Weight and Body Composition in Obese Adolescents. JAMA. 2005;293(23):2873. doi: https://doi.org/10.1001/jama.293.23.2873
52. Mel’nichenko GA, Peterkova VA, Savel’eva LV, Zubkova NA. Evaluation of effectiveness of orlistat in complexed obesity treatment in teenagers with metabolic syndrome. Obesity and metabolism. 2011;8(4):36-42. (In Russ.). doi: https://doi.org/10.14341/2071-8713-5302
53. Freemark M. Pharmacotherapy of Childhood Obesity: An evidencebased, conceptual approach. Diabetes Care. 2007;30(2):395- 402. doi: https://doi.org/10.2337/dc06-1569
54. Sadeghi A, Mousavi SM, Mokhtari T, et al. Metformin Therapy Reduces Obesity Indices in Children and Adolescents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Child Obes. 2020;16(3):174-191. doi: https://doi.org/10.1089/chi.2019.0040.
55. Masarwa R, Brunetti VC, Aloe S, et al. Efficacy and Safety of Metformin for Obesity: A Systematic Review. Pediatrics. 2021;147(3):e20201610. doi: https://doi.org/10.1542/peds.2020-1610
56. Deal CL, Tony M, Höybye C, et al. Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome. J Clin Endocrinol Metab. 2013;98(6):E1072-E1087. doi: https://doi.org/10.1210/jc.2012-3888
57. Lustig RH, Hinds PS, Ringwald-Smith K, et al. Octreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, PlaceboControlled Trial. J Clin Endocrinol Metab. 2003;88(6):2586-2592. doi: https://doi.org/10.1210/jc.2002-030003
58. Lustig RH, Rose SR, Burghen GA, et al. Hypothalamic obesity caused by cranial insult in children: Altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr. 1999;135(2):162-168. doi: https://doi.org/10.1016/S0022-3476(99)70017-X
59. Passone CDGB, Franco RR, Ito SS, et al. Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis. BMJ Paediatr Open. 2020;4(1):e000630. doi: https://doi.org/10.1136/bmjpo-2019-000630
60. Scheermeyer E, Harris M, Hughes I, et al. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens. Growth Horm IGF Res. 2017;34(1):1-7. doi: https://doi.org/10.1016/j.ghir.2017.03.001
61. Lustig RH, Rose SR, Burghen GA, et al. IPEG Guidelines for Surgical Treatment of Extremely Obese Adolescents. J Laparoendosc Adv Surg Tech. 2009;19(1):xiv-xvi. doi: https://doi.org/10.1089/lap.2009.9997
62. Fried M, Hainer V, Basdevant A, et al. Interdisciplinary European Guidelines on Surgery of Severe Obesity. Obes Facts. 2008;1(1):52-59. doi: https://doi.org/10.1159/000113937
63. Pratt JSA, Browne A, Browne NT, et al. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg Obes Relat Dis. 2018;14(7):882-901. doi: https://doi.org/10.1016/j.soard.2018.03.019
64. Till H, Mann O, Singer G, Weihrauch-Blüher S. Update on Metabolic Bariatric Surgery for Morbidly Obese Adolescents. Children (Basel). 2021;8(5):372. doi: 10.3390/children8050372
65. Inge TH, Courcoulas AP, Jenkins TM, et al. Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents. N Engl J Med. 2016;374(2):113-123. doi: https://doi.org/10.1056/NEJMoa1506699
66. Olbers T, Beamish AJ, Gronowitz E, et al. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study. Lancet Diabetes Endocrinol. 2017;5(3):174-183. doi: https://doi.org/10.1016/S2213-8587(16)30424-7
67. Paulus GF, de Vaan LEG, Verdam FJ, et al. Bariatric Surgery in Morbidly Obese Adolescents: a Systematic Review and Meta-analysis. Obes Surg. 2015;25(5):860-878. doi: https://doi.org/10.1007/s11695-015-1581-2
Supplementary files
|
1. Figure 1. Physician’s algorithm for diagnosis and treatment of obesity in children. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(830KB)
|
Indexing metadata ▾ |
Review
For citations:
Vasyukova O.V., Okorokov P.L., Malievskiy O.A., Neimark A.E., Zorin E.A., Yashkov Y.I., Burmitskaya Yu.V., Kopytina D.A., Bezlepkina O.B., Peterkova V.A. Clinical guidelines «Obesity in children». Obesity and metabolism. 2024;21(4):439-453. (In Russ.) https://doi.org/10.14341/omet13194

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).